EMFAT
TMDX icon

Emerald Mutual Fund Advisers Trust’s Transmedics TMDX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.8M Sell
229,326
-575
-0.3% -$75K 1.11% 25
2025
Q4 		$28M Sell
229,901
-8,537
-4% -$1.07M 1.36% 17
2025
Q3 		$26.8M Sell
238,438
-17,205
-7% -$2.01M 1.38% 17
2025
Q2 		$34.3M Sell
255,643
-6,928
-3% -$761K 2.09% 5
2025
Q1 		$17.7M Buy
262,571
+43,296
+20% +$2.98M 1.25% 27
2024
Q4 		$13.7M Buy
219,275
+94,034
+75% +$8.75M 0.83% 47
2024
Q3 		$19.7M Sell
125,241
-123,816
-50% -$19.1M 1.02% 34
2024
Q2 		$37.5M Sell
249,057
-165,457
-40% -$19.8M 1.97% 5
2024
Q1 		$30.6M Buy
414,514
+425
+0.1% +$35K 1.6% 10
2023
Q4 		$32.7M Buy
414,089
+57,342
+16% +$3.46M 1.73% 10
2023
Q3 		$19.5M Buy
356,747
+2,285
+0.6% +$164K 1.18% 21
2023
Q2 		$29.8M Buy
354,462
+1,089
+0.3% +$83.4K 1.61% 7
2023
Q1 		$26.8M Sell
353,373
-88,418
-20% -$6.11M 1.58% 8
2022
Q4 		$27.3M Buy
441,791
+57,344
+15% +$3.05M 1.69% 6
2022
Q3 		$16M Buy
384,447
+37,098
+11% +$1.61M 1.01% 37
2022
Q2 		$10.9M Buy
347,349
+74,944
+28% +$2M 0.63% 62
2022
Q1 		$7.34M Sell
272,405
-28,087
-9% -$503K 0.32% 101
2021
Q4 		$5.76M Sell
300,492
-40,000
-12% -$1M 0.2% 120
2021
Q3 		$11.3M Sell
340,492
-28,767
-8% -$879K 0.39% 86
2021
Q2 		$12.3M Sell
369,259
-231,380
-39% -$6.41M 0.4% 94
2021
Q1 		$24.9M Buy
600,639
+18,125
+3% +$558K 0.83% 46
2020
Q4 		$11.6M Sell
582,514
-25,423
-4% -$376K 0.4% 98
2020
Q3 		$8.38M Hold
607,937
– – 0.37% 84
2020
Q2 		$10.9M Buy
607,937
+183,465
+43% +$2.87M 0.51% 68
2020
Q1 		$5.13M Sell
424,472
-5,396
-1% -$90.4K 0.32% 99
2019
Q4 		$8.17M Buy
429,868
+233,358
+119% +$4.29M 0.33% 104
2019
Q3 		$4.67M Hold
196,510
– – 0.21% 135
2019
Q2 		$5.7M Buy
+196,510
New +$5.36M 0.23% 129

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TMDX Position: Q1 2026 in Review

Emerald Mutual Fund Advisers Trust reduced its Transmedics (TMDX) stake by 0.25% in Q1 2026, selling an estimated $75K and leaving 229,326 shares worth $22.8M. The position accounts for 1.11% of the portfolio, ranked #25.

Emerald Mutual Fund Advisers Trust first reported a position in TMDX in Q2 2019 and has held it in 28 quarters since. The position peaked at $37.5M in Q2 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Emerald Mutual Fund Advisers Trust held 229,326 shares of Transmedics worth $22.8M as of Q1 2026.
  • Emerald Mutual Fund Advisers Trust sold 575 Transmedics shares in Q1 2026, an estimated $75K.
  • Transmedics made up 1.11% of Emerald Mutual Fund Advisers Trust's portfolio in Q1 2026, its #25 holding.
  • Emerald Mutual Fund Advisers Trust first reported a position in Transmedics in Q2 2019 and has held it in 28 quarters since.
  • Emerald Mutual Fund Advisers Trust's Transmedics position peaked at $37.5M in Q2 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2026, filed 4 May 2026.